about
Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseasesAntifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver diseaseVitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseasesAntifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver diseaseHuman recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesVitamin K for upper gastrointestinal bleeding in patients with liver diseasesAntacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patientsHuman recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesAntifibrinolytic amino acids for acquired coagulation disorders in patients with liver diseaseCoagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow upCoagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.Blood platelet and monocyte activations and relation to stages of liver cirrhosisReview article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No, but they need a careful look.Spectrum of anemia associated with chronic liver disease.New insights into the coagulopathy of liver disease and liver transplantationRetinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C.Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers.Infection, coagulation, and variceal bleeding in cirrhosis.The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients.Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C.Monitoring coagulation proteins during progression of liver disease.Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis.Association between plasma fibrinogen levels and mortality in acute-on-chronic hepatitis B liver failure.Advances in critical care hepatology.Modelling Factors Causing Mortality in Oesophageal VaricesPatients in King Abdul Aziz University HospitalLiver dysfunction as an important predicting risk factor in patients undergoing cardiac surgery: a systematic review and meta-analysis.Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.Management of bleeding emergencies: when to use recombinant activated factor VII.The rule of four: a systematic approach to diagnosis of common pediatric hematologic and oncologic disorders.Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational StudyEvaluation of coagulation parameters and liver enzymes among alcohol drinkers in Port Harcourt, NigeriaCHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor.Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study.A Cell-type-resolved Liver Proteome.Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors.Serotype-specific host responses in rhesus macaques after primary dengue challenge.Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease.
P2860
Q24187239-299DED52-F460-4D70-82F0-3C657DEA4C24Q24187246-4F31B2C0-0A8A-44AE-B898-7C82E38A56AEQ24200416-D019E67B-958B-444E-89E2-B44F5B7CC10CQ24200420-33009F29-A418-4B23-8911-FB7217644D33Q24201303-C8D42008-E1A3-491F-956A-E4B43F9334CFQ24241921-16217CE7-EA1C-451D-82DE-61883B490CB3Q24242984-C51A332E-C082-41F2-8D73-6267BD393B30Q24246238-9348A578-2001-4798-B94B-8E5DDA7C01A8Q24246487-FA4C6DBE-2AE4-498F-A0D8-C7F011A7CC9CQ28211863-9D9C29B4-BAD0-4FA4-8992-1589FC3C69B4Q30441096-6C6210CD-C4F2-4046-9152-27C0D20307E6Q33366214-5C59A2CF-D38D-455F-A250-624CB92C3558Q33370831-03983E76-297E-42A2-8A38-8C8C8587FA47Q33371692-8E425F37-FE76-4F48-BDD8-699D6D094FAAQ33386418-CF521394-E97C-4676-9AB5-1C8998BC6B19Q33866656-A2017928-ACE2-415E-8F86-1C54F014239FQ33867071-35D14344-6BAE-44DE-BDFA-BF9D568D2ED0Q33867515-BDE2031D-AD6A-4940-ADF3-536790D0905FQ34400962-19B49C5A-CE70-4A09-AF6E-973A030F1EBDQ34552460-6739F0CB-022A-48D4-A0DE-723D7B5725B4Q34999188-BAC8AFA1-45AD-4A94-AF7C-C682F8768280Q35099749-67721F03-1B84-4DA3-94FA-3BA9875AFDDEQ35365653-A06130F5-72B6-491E-87C6-334A0B4E6F13Q35486931-E6164B5A-5CA4-4527-8AB7-04F7F8C7ABA7Q35557311-50A9E2F6-40E5-4957-80F0-8AF0992D3506Q35605215-838FAF52-741C-4B80-8B6D-20F76E6E0014Q35651508-CDB319D1-D31D-4F1D-9443-98FDB2D41DDBQ35925720-1767DD0F-C0DE-4DD0-A417-E92ACAB80A0EQ36284359-07C2C35E-D2F5-4C2F-AEFF-3A6F6147B640Q36349585-5E8AE1A9-719F-4AB6-8857-F805E0F7F667Q36500415-5FA764C5-8023-47C0-B31A-AFFFA70554FCQ36733711-67B9C083-CC2F-4F4E-949B-37FC6B79F552Q36936892-47BA2E0D-DF02-4A87-BF0E-EF3743D458C3Q36951765-F90D8BE9-66AE-43DB-911B-C10BDD02ADC7Q36988001-751359D8-8D35-49BB-BECD-7A2B86E55F18Q37210089-57B0E6DB-06E9-4253-A8DC-D854BA9E273BQ37318955-7208F632-5EF2-41BC-91B7-517830240C61Q37322221-629AB10E-9B44-4035-8E54-0A4D4E3BF68FQ37372592-73386866-B33C-4F87-91EA-BA6AEF55A8CFQ37682987-6575D22A-E501-41DF-B117-FF90E0F3F14F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Coagulation disorders in liver disease.
@ast
Coagulation disorders in liver disease.
@en
type
label
Coagulation disorders in liver disease.
@ast
Coagulation disorders in liver disease.
@en
prefLabel
Coagulation disorders in liver disease.
@ast
Coagulation disorders in liver disease.
@en
P2093
P356
P1476
Coagulation disorders in liver disease.
@en
P2093
Antonio Balzano
Lucio Amitrano
Maria A Guardascione
Vincenzo Brancaccio
P356
10.1055/S-2002-23205
P577
2002-02-01T00:00:00Z